The resulting genome-wide co-expression profiles spotlighted TTLL11 as the TTLL glutamylase with the strongest tumor-specific co-expression signature that deviates from the expression pattern found in the corresponding normal tissues (Supplementary Fig 8a). This evidence concerns the gene TTLL11 and neoplasm.